Zara Baloch, Peer Reviewer at Journal of Breakthroughs in Medicine and Science, shared on LinkedIn:
“What is actually changing in how we diagnose and treat primary brain tumors?
We recently featured Dr. Morana Vojnic, Director of Neuro-Oncology at Rutgers Cancer Institute and System Leader for Neuro-Oncology at RWJBarnabas Health, in this MedNews Week × OncoDaily discussion.
Dr. Vojnic shares her perspective on the rapidly evolving role of molecular testing in gliomas – from IDH mutations and 1p/19q co-deletion to targeted therapies, liquid biopsy, AI in neuro-oncology, and the challenges that remain in high-grade disease.
A thoughtful conversation on where precision neuro-oncology is heading and how molecular profiling is increasingly shaping clinical decision-making.
Watch the full discussion here.”
Other articles about neuro-oncology on OncoDaily.
